Native and modified low-density-lipoprotein interaction with human platelets in normal and homozygous familial-hypercholesterolaemic subjects
- 15 November 1984
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 224 (1) , 13-20
- https://doi.org/10.1042/bj2240013
Abstract
The binding of low density lipoproteins (LDL) as well as LDL modified by cyclohexanedione (CHD-LDL) to gel-filtered platelets (GFP), and its effect on platelet function were studied in normal and in homozygous familial hypercholesterolemic (HFH) subjects [plays a major role in atherosclerosis]. Only normal-derived LDL could significantly compete with normal 125I-labeled LDL for binding to normal platelets. When GFP from normal subjects were incubated with normal LDL at concentrations of 25-200 .mu.g of protein/ml, platelet aggregation in the presence of thrombin (0.5 IU/ml) was increased by 65-186%. CHD-LDL, at similar concentrations, caused the opposite effect and decreased platelet aggregation by 26-47%. Both LDL and CHD-LDL (100 .mu.g/ml) from HFH patients, when incubated with normal GFP, caused a significant reduction in platelet aggregation (33 and 50%, respectively). When HFH-derived platelets were used, both patient LDL and CHD-LDL (but not the normal lipoprotein) could markedly compete with the patient 125I-labeled LDL for binding to the platelets. LDL and CHD-LDL (100 .mu.g/ml) from normal subjects decreased aggregation of HFH-platelets by 52 and 85%, respectively, while corresponding concentrations of LDL derived from HFH subjects (HFH-LDL) and CHD-LDL derived from HFH subjects (CHD-HFH-LDH) increased platelet aggregation by 165 and 65%, respectively. The following conclusions are supported: platelet activation by LDL in normal subjects is through the arginine-rich apoprotein-binding site; more than one binding site for LDL exists on platelets; under certain circumstances, LDL binding can cause a reduction in platelet activity; specificity for LDL binding to the platelets resides in different regions of the lipoprotein in HFH and in normal subjects. A model for LDL-platelet interaction in normal and in HFH subjects was suggested.This publication has 27 references indexed in Scilit:
- Abnormal plasma lipoprotein composition in hypercholesterolaemic patients induces platelet activationEuropean Journal of Clinical Investigation, 1984
- Defective Lipoprotein Receptors and AtherosclerosisNew England Journal of Medicine, 1983
- Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patientsBiochemical Medicine, 1983
- Characterization of the Effect of Plasma Lipoproteins on Platelet Function in vitroPathophysiology of Haemostasis and Thrombosis, 1983
- Specific Binding Sites on Human Blood Platelets for Plasma LipoproteinsHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1982
- Low density lipoprotein binding to human platelets: Role of charge and of specific amino acidsBiochemical and Biophysical Research Communications, 1981
- Reversible abnormalities of low density lipoprotein composition in familial hypercholesterolaemiaEuropean Journal of Clinical Investigation, 1979
- Uptake and degradation of low density lipoprotein by swine arterial smooth muscle cells with inhibition of cholesterol biosynthesisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1976
- Platelet hypersensitivity induced by cholesterol incorporation.Journal of Clinical Investigation, 1975
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962